Total cost comparison in relapsed/refractory multiple myeloma.

Total cost comparison in relapsed/refractory multiple myeloma.

Item
http://www.wikidata.org/entity/Q34088340
Smoldering multiple myeloma requiring treatment: time for a new definition?Double Relapsed and/or Refractory Multiple Myeloma: Clinical Outcomes and Real World Healthcare CostsQuality-adjusted cost of care: a meaningful way to measure growth in innovation cost versus the value of health gainsEstimating the Costs of Therapy in Patients with Relapsed and/or Refractory Multiple Myeloma: A Model Framework.A review of economic impact of targeted oral anticancer medications.Clinical utility and patient consideration in the use of lenalidomide for multiple myeloma in Chinese patients.Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective.Clinical epidemiology and treatment patterns of patients with multicentric Castleman disease: results from two US treatment centres.Preclinical evaluation of bortezomib/dipyridamole novel combination as a potential therapeutic modality for hematologic malignancies.Economic burden of multiple myeloma among patients in successive lines of therapy in the United States.
P2860

Total cost comparison in relapsed/refractory multiple myeloma.

Item
http://www.wikidata.org/entity/Q34088340
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Total cost comparison in relapsed/refractory multiple myeloma.
@ast
Total cost comparison in relapsed/refractory multiple myeloma.
@en
Total cost comparison in relapsed/refractory multiple myeloma.
@nl
type
label
Total cost comparison in relapsed/refractory multiple myeloma.
@ast
Total cost comparison in relapsed/refractory multiple myeloma.
@en
Total cost comparison in relapsed/refractory multiple myeloma.
@nl
prefLabel
Total cost comparison in relapsed/refractory multiple myeloma.
@ast
Total cost comparison in relapsed/refractory multiple myeloma.
@en
Total cost comparison in relapsed/refractory multiple myeloma.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Total cost comparison in relapsed/refractory multiple myeloma.
@en
P2093
P2860
P304
P31
P356
10.3111/13696998.2012.760159
P407
P433
P478
P577
P5875
P698
P932